ALPHA-INTERFERON IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES

被引：85

作者：

ROTH, MS ^{[1
]}

FOON, KA ^{[1
]}

机构：

[1] UNIV MICHIGAN,DEPT MED,DIV HEMATOL & ONCOL,ANN ARBOR,MI 48109

来源：

AMERICAN JOURNAL OF MEDICINE | 1986年 / 81卷 / 05期

关键词：

D O I：

10.1016/0002-9343(86)90360-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：871 / 882

页数：12

共 140 条

[91]

MEURER SC, 1982, P NATL ACAD SCI USA, V79, P4395

[92]

MISSET JL, 1982, BIOMED PHARMACOTHER, V36, P112

[93] CLINICAL-TRIAL OF RECOMBINANT LEUKOCYTE-A INTERFERON AS INITIAL THERAPY FOR FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMAS AND CHRONIC LYMPHOCYTIC-LEUKEMIA AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY [J].

OCONNELL, MJ ;

COLGAN, JP ;

OKEN, MM ;

RITTS, RE ;

KAY, NE ;

ITRI, LM .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :128-136

[94]

OHNO R, 1986, CANCER, V57, P1685, DOI 10.1002/1097-0142(19860415)57:8+<1685::AID-CNCR2820571310>3.0.CO

[95]

2-0

[96] AUGMENTATION OF HUMAN K-CELL ACTIVITY WITH INTERFERON [J].

ORTALDO, JR ;

PESTKA, S ;

SLEASE, RB ;

RUBINSTEIN, M ;

HERBERMAN, RB .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1980, 12 (05) :365-369

[97]

OSSERMAN EF, 1980, P AM ASSOC CANC RES, V21, P161

[98]

OZER H, 1983, J BIOL RESP MODIF, V2, P499

[99]

OZER H, 1983, AM SOC HEMATOL, V62, pA211

[100]

PESTKA S, 1983, SCI AM, V249, P37

← 5 6 7 8 9 10 11 12 13 14 →